Jump to ContentJump to Main Navigation
Show Summary Details

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew

1 Issue per year

IMPACT FACTOR increased in 2015: 0.190
5-year IMPACT FACTOR: 0.221

SCImago Journal Rank (SJR) 2015: 0.140
Source Normalized Impact per Paper (SNIP) 2015: 0.154
Impact per Publication (IPP) 2015: 0.197

Open Access
See all formats and pricing
Volume 8, Issue 1 (Feb 2013)


Risk factors for cervical cancer among young women

Małgorzata Wężowska
  • Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents PUM, 70-111, Szczecin, Poland
  • Email:
/ Stefania Giedrys-Kalemba
  • Department of Microbiology and Immunology PUM, 70-111, Szczecin, Poland
  • Email:
/ Ludmiła Szymaniak
  • Department of Microbiology and Immunology PUM, 70-111, Szczecin, Poland
  • Email:
/ Żaneta Borowiec-Chłopek
  • Department of Microbiology and Immunology PUM, 70-111, Szczecin, Poland
  • Email:
/ Violetta Konstanty-Kurkiewicz
  • Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents PUM, 70-111, Szczecin, Poland
  • Email:
/ Janusz Menkiszak
  • Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents PUM, 70-111, Szczecin, Poland
  • Email:
Published Online: 2012-12-08 | DOI: https://doi.org/10.2478/s11536-012-0063-3
  • [1] Sikorski M., Majewski S., Zmiany chorobowe związane przyczynowo z zakażeniami HPV, Przew. Lek 2008, 1, 234–246

  • [2] Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV., The causal relation between human papillomavirus and cervical cancer, J Clin Pathol 2002, 55, 24–465 http://dx.doi.org/10.1136/jcp.55.4.244 [Crossref]

  • [3] Kędzia W., Etiopatogeneza raka szyjki macicy W: Ginekologia Onkologiczna tom I Red. Markowska J., Wrocław Urban & Partner 2006, 513–520

  • [4] Bosch FX et al., Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain, J Natl Cancer Inst 1996, 88, 1060 http://dx.doi.org/10.1093/jnci/88.15.1060 [Crossref]

  • [5] Schiffman M., Wentzensen N., From human papillomavirus to cervical cancer, Obstetrics & Gynecology 2010, 116: 177–185 http://dx.doi.org/10.1097/AOG.0b013e3181e4629f [Crossref]

  • [6] Michalska M., Epidemiologia raka szyjki macicy. W: Rak szyjki macicy. Profilaktyka, diagnostyka i leczenie. Red. Spaczyński M., PZWL 2009, 1–15

  • [7] Moscicki AB., Impact of HPV infection In adolescent populations., J Adolesc Health. 2005, 37, 3–9 http://dx.doi.org/10.1016/j.jadohealth.2005.09.011 [Crossref]

  • [8] Castellasagué X., Bosch F.X., Muñz N., at al., Male circumcision penile human papillomavirus infection and cervical cancer in female partners, N Engl J Med 2002, 346,15, 1105–1112 http://dx.doi.org/10.1056/NEJMoa011688 [Crossref]

  • [9] Au W.W., Abdou-Salama S., Sierra-Torres C.H., at al, Environmental risk factors for prevention and molecular intervention of cervical cancer, Int J Hyg Environ Health. 2007, 210(6), 671–678 http://dx.doi.org/10.1016/j.ijheh.2006.10.003 [Crossref] [Web of Science]

  • [10] Collins S., Rollason T.P., Young L.S., at al., Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study. Eur J Cancer 2010., 46(2), 405–411 http://dx.doi.org/10.1016/j.ejca.2009.09.015 [Web of Science] [Crossref]

  • [11] Muñoz N., Bosch F.X., Cervical cancer and human papillomavirus: Epidemiological evidence and prospective for prevention, J Natal Cancer Inst. 1995, 87, 796–802 http://dx.doi.org/10.1093/jnci/87.11.796 [Crossref]

  • [12] Deligeoroglou E., Michailidis E., Creatsas G., Oral contraceptives and reproductive system cancer., Ann N Y Acad Sci. 2003, 997, 199–208 http://dx.doi.org/10.1196/annals.1290.023 [Crossref]

  • [13] Confortini M., Carozzi F., Zappa M., at al., Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18–24: results at recruitment., BMC Infect Dis. 2010, 10, 157 http://dx.doi.org/10.1186/1471-2334-10-157 [Crossref]

  • [14] Porras C., Bennett Ch., Safaeian M., at al., Determinants of seropositivity among HPV — 16/18 DNA positive young women, BMC Infect Dis. 2010, 10, 238

  • [15] Soto — De Leon S., Camargo M., Sanchez R., at al., Distribution patterns if infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One 2011, 6, e14705 http://dx.doi.org/10.1371/journal.pone.0014705 [Crossref]

  • [16] Jin Q., Shen K., Zhou XR., at al., Prevalence of human papillomavirus infection in women in Tibet Autonomous Region of China., Zhoughua Fu Chan Ke Za Zhi 2009, 44, 898–902

  • [17] Cercato MC., Mariani L., Vocaturo A., at al., Predictors of human papillomavirus (HPV) infection in Italian women, J Med Virol.2010, 82, 1921–1927 http://dx.doi.org/10.1002/jmv.21887 [Web of Science] [Crossref]

  • [18] Forhan S., Gottlieb S., Sternberg M., at al., Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States, Pediatrics. 2009, 124, 1505–1512 http://dx.doi.org/10.1542/peds.2009-0674 [Crossref]

  • [19] Papachristou E., Sypsa V., Paraskevis D., at al., Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test, J Med Virol. 2009, 81, 2059–2065 http://dx.doi.org/10.1002/jmv.21639 [Web of Science] [Crossref]

  • [20] Shickary T., Bernstein D., Jin Y., at al., Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low — income young women, J Clin Virol. 2009, 46, 107–111 http://dx.doi.org/10.1016/j.jcv.2009.07.006 [Crossref]

  • [21] Lenselink Ch., Melchers W., Qiunt W., at al., Sexual behavior and HPV infections in 18 to 29 year old women in the pre — vaccine era in the Netherlands, PLoS One 2008, 3, e3743 http://dx.doi.org/10.1371/journal.pone.0003743 [Crossref]

  • [22] Menegazzi P., Barzon L., Palù G., at al., Human papillomavirus type distribution and correlation with cyto — histological patterns in women from the south of Italy, Infect Dis Obstet Gynecol 2009, 198425

  • [23] Uusküla A., Kals M., Kosenkranius L., at al., Population — based type — specific prevalence of high — risk human papillomavirus infection in Estonia, BMC Infect Dis. 2010, 10, 63 http://dx.doi.org/10.1186/1471-2334-10-63 [Crossref]

  • [24] Boardman L., Stanko C., Weitzen S., at al., Atypical squamous cells of undetermined significance: Human papillomavirus testing in adolescents, Obstet. Gynecol. 2005, 105, 741–746 http://dx.doi.org/10.1097/01.AOG.0000157126.12678.a6 [Crossref]

  • [25] Wright J., Rader J., Davila R., at al., Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. Obstet. Gynecol. 2006, 107, 822–829 http://dx.doi.org/10.1097/01.AOG.0000207557.30226.25 [Web of Science] [Crossref]

  • [26] Allen GL., Klobocista MM., Sugarman S., at al., Prevalence of high — risk human papillomavirus in an inner — city population with atypical squamous cells of undetermined significance, J Low Genit Tract Dis. 2009, 13, 63–65 http://dx.doi.org/10.1097/LGT.0b013e318186d76a [Crossref]

  • [27] González C., Canals J., Ortiz M., at al., Prevalence and determinants of high — risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women, Epidemiol. Infect. 2008, 136, 215–221 http://dx.doi.org/10.1017/S0950268807008382 [Crossref] [Web of Science]

  • [28] Moscicki AB., Ma Y. Wibbelsman Ch., at al., Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology, Obstet. Gynecol. 2008, 112, 1335–1342 http://dx.doi.org/10.1097/AOG.0b013e31818c9222 [Crossref]

  • [29] Case AS., Rocconi RP., Straughn JM Jr., at al., Cervical intraepithelial neoplasia in adolescent women, Obstet. Gynecol 2006., 108, 1369–1374 http://dx.doi.org/10.1097/01.AOG.0000245448.19446.81 [Crossref]

  • [30] Nawarra — Karowicz D., Kowalska — Koprek U., Karowicz — Bilińska A., Ocena wystąpienia czynników ryzyka zakażenia wirusem brodawczaka ludzkiego (HPV) oraz stopnia jego onkogenności wśród mieszkanek wsi, Przegląd menopauzalny 2005, 4, 22–31

  • [31] Sarian L.O., Hammes L.S., Longatto-Filho A., at al., Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study, Sex Transm Dis. 2009, 36(4), 241–248 http://dx.doi.org/10.1097/OLQ.0b013e3181935a7d [Web of Science] [Crossref]

  • [32] Silva KC., Rosa MLG., Moyses N., at al., Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil, Mem Inst Oswaldo Cruz. 2009, 104, 885–891 http://dx.doi.org/10.1590/S0074-02762009000600011 [Crossref] [Web of Science]

  • [33] Cotton SC., Sharp L., Seth L., at al., Lifestyle and socio-demographic factors associated with high — risk HPV infection in UK women, Br J Cancer. 2007, 97, 133–139 http://dx.doi.org/10.1038/sj.bjc.6603822 [Web of Science] [Crossref]

  • [34] Ripabelli G., Grasso GM., Del Riccio I., at al., Prevalence and genotype identification of human pappilomavirus in women undergoing voluntary cervical cancer screening in Molise, central Italy, Cancer Epidemiol. 2010, 34, 162–167 http://dx.doi.org/10.1016/j.canep.2009.12.010 [Crossref] [Web of Science]

  • [35] Kanato M., Saranrittichai K., Early experience of sexual intercourse — a risk factor for cervical cancer requiring specific intervention for teenagers, Asian Pacific J Cancer Prev. 2006, 7, 151–153

  • [36] Sellous JW., Karwalajtys TL., Kaczorowski J., at al., Incidence, clearance and predictors of human papillomavirus infection in women, CMAJ 2003, 168, 421–425

  • [37] Nielsen A., Kjaer SK., Munk C., at al., Type — specyfic HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12 000 younger and older Danish women, Sex Transm Dis. 2008, 35, 276–282 http://dx.doi.org/10.1097/OLQ.0b013e31815ac5c7 [Crossref]

  • [38] Chan JK., Monk BJ., Brewer C., at al., HPV infection and number of lifetime sexual partners are strong predictors for natural regression of CIN 2 and, Br J Cancer. 2003, 89, 1062–1066 http://dx.doi.org/10.1038/sj.bjc.6601196

  • [39] Menéndez C., Castellsagué X., Renom M., at al., Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rual area of southern Mozambique, Infect Dis Obstet Gynecol. 2010, 609315

  • [40] Lippman SA., Sucupira MC., Jones HE., at al., Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women, Int J STD AIDS. 2010, 21, 105–109 http://dx.doi.org/10.1258/ijsa.2009.008436 [Crossref]

  • [41] Green J., Berrington de Gonzalez A., Smith JS., at al., Human papillomavirus infection and use of oral contraceptives, Br J Cancer. 2003, 83, 1713–1720 http://dx.doi.org/10.1038/sj.bjc.6600971 [Crossref]

  • [42] Vaccarella S., Herrero R., Dai M., at al., Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys, Cancer Epidemiol Biomarkers Prev. 2006, 15, 2148–2153 http://dx.doi.org/10.1158/1055-9965.EPI-06-0556 [Crossref]

  • [43] Flores YN., Bishai DM., Shah KV., at al., Risk factors for cervical cancer among HPV positive women in Mexico, Salud Publica Mex. 2008, 50, 49–58 http://dx.doi.org/10.1590/S0036-36342008000100011 [Crossref]

  • [44] Benard VB., Johnson TD., Roland KB., at al., Examining the association between socioeconomic status and potential human papillomavirus — associated cancers, Cancer. 2008, 113(10 Suppl), 2910–2918 http://dx.doi.org/10.1002/cncr.23742 [Crossref]

About the article

Published Online: 2012-12-08

Published in Print: 2013-02-01

Citation Information: Open Medicine, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-012-0063-3. Export Citation

© 2012 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Comments (0)

Please log in or register to comment.
Log in